Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

21 results
  1. NLM Digital Collections - Management of adult testicular germ cell tumours : a national clinical guideline 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), March 2011
    ... approaches are under evaluation including dose escalation of cisplatin, alternating regimens and reduction of inter-cycle interval-accelerated chemotherapy. ...
  2. NLM Digital Collections - Management of lung cancer : a national clinical guideline 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), February 2014
    ... A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent. Br ...
  3. NLM Digital Collections - Chimeric antigen receptor T-cell therapy for B-cell cancers : effectiveness and value : final ... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, March 23, 2018
    ... high- dose therapy, NCCN recommends the following chemotherapy regimens, with or without rituximab: DHAP (dexamethasone, cisplatin, cytarabine), ESHAP (etoposide, methylprednisolone, cytarabine, cisplatin), GDP (gemcitabine, ...
  4. NLM Digital Collections - Poly ADP-ribose polymerase (PARP) inhibitors for ovarian cancer : effectiveness and value : ... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, September 28, 2017
    ... postoperative/adjuvant therapy with a platinum (e.g., cisplatin, carboplatin) and a taxane agent (e.g., paclitaxel, docetaxel) or liposomal doxorubicin.7-9 For recurrence, several chemotherapy regimens (e.g., docetaxel, paclitaxel, gemcitabine, liposomal doxorubicin, topotecan ...
  5. NLM Digital Collections - FDA oversight 
    Publication: [Toronto, Ontario] : Thomson Reuters, 21-December-2020
    ... In 2004, FDA approved pemetrexed in combination with cisplatin for this indication, and now patients now have an important, additional treatment option after more than a decade with only one FDA-approved drug regimen.” Malignant pleural mesothelioma (MPM) is a life-threatening ...
  6. NLM Digital Collections - Medication errors in outpatient hematology and oncology clinics 
    Publication: [Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, December 2017
    ... patient received four cycles of EP (etoposide and CISplatin) over two ... regimen. The most commonly reported medication classes associated with ...
  7. ... 347-51. Economic value of gemcitabine compared to cisplatin and etoposide in ... chemotherapic regimens for non-surgical non-small cell lung cancer. ...
  8. NLM Digital Collections - Management of epithelial ovarian cancer : a national clinical guideline 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), 2013
    ... CHOICE OF PLATINUM AGENTS The platinum based drugs cisplatin and carboplatin are equally efficacious in the treatment ... carboplatin and 1++ paclitaxel is as efficacious as cisplatin and paclitaxel combination therapy.130 A Carboplatin is ...
  9. NLM Digital Collections - S5(R3) detection of reproductive and developmental toxicity for human pharmaceuticals 
    Publication: Silver Spring, MD : Center for Drug Evaluation and Research, May 2021
    ... Busulfan X X X Carbamazepine X X X Cisplatin X Cyclophosphamide X X X Cytarabine X X ... invariant across dose levels.) 57 Contains Nonbinding Recommendations CISPLATIN CAS No.: 15663-27-1 Rat NOAEL Rat ...
  10. NLM Digital Collections - SUMEX renewal application 
    Publication: Produced: 1 June 1985
    ... teaching tool. 6. Jacobs C. The role of cisplatin in the treatment of rec Cisplatin Current Status and New Developments. Carter SK. Academic ... M, Carter S. A randomized phase III study of cisplatin with or without methotrexate for recurrent squamous Cell ...
previous · 1 · 2 · next